Abstract:Yuyao Li, 1, &ast Yue Li, 1, &ast Jinghao Zhang, 2 Longshan Ji, 3 Man Li, 3 Xuehua Sun, 2 Hai Feng, 1 Zhuo Yu, 2 Yueqiu Gao 1, 2 1 Institute of Infectious Disease, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, People's Republic of China; 2 Department of Liver Disease, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, People's Republic of China; 3 Laboratory of Cellular Immunity, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, People's Republic of China &astThese authors contributed equally to this work Correspondence: Zhuo Yu; Yueqiu Gao, Department of Liver Disease, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, No. 528 Zhangheng Road, Pudong New District, Shanghai, 201203, People's Republic of China, Tel +86 21 2025 6507, Fax +86 21 20256699, Email ; Hepatocellular carcinoma (HCC) is one of the leading lethal tumors worldwide, and the treatment remains a great medical challenge. Surgery and chemotherapy are current standard curative methods for patients with HCC, but the prognosis is still dismal. Based on unique medical theories and rich practical experience, traditional Chinese medicine (TCM) has been broadly employed to effectively treat HCC for a long history. Recently, systematic clinical trials have been well designed to study the efficacy of TCMs in the treatment of HCC, and the underlying antitumor mechanisms were also deeply explored. Here, we reviewed the published clinical evaluation of some commonly used TCMs in the treatment of HCC, and the related anti-HCC mechanisms through in vitro and in vivo study, promoting the modernization of TCM study in oncology for achieving a substantial reduction of HCC burden in the future. Keywords: traditional Chinese medicine, hepatocellular carcinoma, antitumor mechanism, tumor therapy, active ingredient Hepatocellular carcinoma (HCC) ranks the sixth most common malignant neoplasm and the third cancer-caused death worldwide. 1 Epidemiology demonstrated that the incidence of HCC is still rapidly increasing globally, especially in Europe and the United States. 2 Although multiple noninvasive imaging-based surveillance avenues have been developed for the diagnosis of HCC, the beneficiary effect is limited by the uncertain presentation of HCC pathological changes in early stage. 3 Surgical resection and liver transplantation are the current standard curative avenues for patients with regional HCC in early stage. However, the medical difficulties including high frequency of postoperative recurrence and the scarcity of donor liver resource seriously weaken the therapeutic efficacy on patients. 4 Multi-kinase inhibitors including sorafenib and regorafenib have been approved to treat the unresectable or advanced HCC, but the improvement of patient survival quality is restricted due to drug resistance caused by the long-term administration. 5 Therefore, other effective alternative therapeutic strategies with lower cost and fewer side effects are urgently required for the treatment of HCC. Traditional Chinese medicine (TCM) has a long history for the treatment of cancer including HCC. The plethora of accumulated experience in the long-term therapeutic practice promotes the construction of unique medical theories of TCM. The holism of human body and the concept of treatment according to syndrome differentiation are the central foundation of these theories and become the vital principle of TCM in the diagnosis and treatment of cancer. In these theories, liver is the soul of the human body, functioning to store the blood, control the sinews, and maintain a smooth and uninterrupted flow of qi . 6 HCC is the consequence of systemic disease with causative cumulative toxicity, vital qi deficiency and qi flow stasis, leading to the disequilibrium of yin and yang . Therefore, the purpose of TCM treatment is to restore the balance of yin and yang in the body and keep the smooth flow of qi . The strategy of TCM in the treatment of HCC is to exert multiple methods according to different syndromes while treating the patients as a whole at the same time. Treatment methods, including nourishing yin , heat-clearing and detoxifying, invigorating blood and removing stasis, softening and resolving hard mass, and soothing liver qi stagnation, are correspondingly used upon these TCM theories to effectively improve the overall survival of patients with HCC. 7 Formula (Fufang) that int -Abstract Truncated-

The Therapeutic Significance of the Theory of "Treating Liver by Nourishing Spleen" in Primary Liver Cancer

Overview of Clinical and Experimental Study on Spleen-Nourishing and Qi-Regulating Therapy for Liver Cancer

Reinforcing Spleen Yin Principle Treating Advanced HCC

On the Theoretical Basis and Applied Research of "Spleen and Stomach as the Foundation"

Restoring the Harmony and Order of the Body: Treatment of Cancer Patients According to Syndrome Differentiation

[Regularity analysis on clinical treatment in primary liver cancer by traditional Chinese medicine]

Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition).

The Therapeutic Principle of Combined Strengthening Qi and Eliminating Pathogens in Treating Middle-Advanced Primary Liver Cancer: A Systematic Review and Meta-Analysis

Application and Perspectives of Traditional Chinese Medicine in the Treatment of Liver Cancer

Treatment of Liver Cancer: Role of the Traditional Mongolian Medicine

Integrated Plasma Metabolomics and Gut Microbiota Analysis: The Intervention Effect of Jiawei Xiaoyao San on Liver Depression and Spleen Deficiency Liver Cancer Rats

Traditional Chinese medicine as supportive care for the management of liver cancer: Past, present, and future

Guidelines for the Diagnosis and Treatment of Primary Liver Cancer (2022 Edition)

On the Core Prescriptions and Their Mechanisms of Traditional Chinese Medicine in Hepatitis B, Liver Cirrhosis, and Liver Cancer Treatment

The Importance of Regulating the Liver in Process of Esophageal Carcinoma Treating from the Theory of Liver Treatment

Theoretical Exploration into Treatment of Atherosclerosis by Nourishing Kidney and Liver, Resolving Phlegm and Removing Blood Stasis

Current Perspective of Traditional Chinese Medicines and Active Ingredients in the Therapy of Hepatocellular Carcinoma

[Exploring the pathogenesis and therapy of liver cancer from "damp-heat insidious pathogen" to "cancer toxin"]

Clinical practice guidelines for the treatment of primary liver cancer with integrative traditional Chinese and Western medicine

Discussion on Application of Strengthening Body Resistance and Eliminating Evil in the Treatment of Liver Cancer